Drug intelligence / Profile preview

Shufeng Huoluo Pill

Development stage
Unknown
Lead developer
Lei Yun Shang
Modality
Small Molecules
Administration
Oral
01

Overview

Shufeng Huoluo Pill (疏风活络丸) is a traditional Chinese medicine (TCM) formulation manufactured by Changchun Leiyunshang Pharmaceutical, a subsidiary of the historic Leiyunshang Pharmaceutical Group. This oral pill is an approved pharmaceutical product in China, primarily indicated for conditions traditionally described as 'wind-dampness' obstruction, which typically correlate with rheumatic pain, joint stiffness, and limb numbness. The formulation contains several active alkaloid compounds, including pseudoephedrine, ephedrine, strychnine, and brucine. Following TCM theory, the drug is designed to expel pathogenic wind, transform phlegm, and activate the collaterals to alleviate pain and improve mobility. While the specific molecular targets are not formally defined in its regulatory approval, the presence of potent alkaloids suggests a complex pharmacological profile typical of modernized TCM preparations.

Brand names
Shufeng Huoluo Pill疏风活络丸
Other names
Shufeng Huoluo Wan
02

Targets

IL1B (Interleukin-1 beta)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)TP53 (Cellular Tumor Antigen p53 R175H)BCL-2 (BCL-2 family)EGFR T790M (Epidermal growth factor receptor T790M mutant)

Beyond the preview

Go deeper on Shufeng Huoluo Pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shufeng Huoluo Pill.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call